Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus
The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated...
Saved in:
Published in | Journal of diabetes and its complications Vol. 31; no. 10; pp. 1499 - 1505 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications.
We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured.
The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors.
Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.
•Serum angiotensin-II concentration increases from prediabetic condition.•Serum angiotensin-II was independently associated with urine albumin excretion after adjusting for multiple risk factors.•Angiotensin-II plays a critical role in the pathophysiology of microvascular complications of diabetes. |
---|---|
AbstractList | The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications.
We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured.
The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors.
Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.
•Serum angiotensin-II concentration increases from prediabetic condition.•Serum angiotensin-II was independently associated with urine albumin excretion after adjusting for multiple risk factors.•Angiotensin-II plays a critical role in the pathophysiology of microvascular complications of diabetes. The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications.OBJECTIVESThe relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications.We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured.METHODSWe investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured.The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors.RESULTSThe mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors.Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism.CONCLUSIONSAngiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism. Objectives The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications. Methods We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured. Results The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m2, respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors. Conclusions Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism. The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components comprehensively were limited. We hypothesized that serum RAS components, especially the effector peptide angiotensin-II, might be closely associated with glucose metabolism status and diabetic complications. We investigated the association of individual RAS component with albuminuria in 407 subjects with normal glucose metabolism (NGM), prediabetes, or type 2 diabetes mellitus (T2DM). Anthropometric and biochemical parameters, including glucose homeostasis, albuminuria, and RAS-related parameters such as plasma renin activity (PRA), aldosterone, angiotensin-converting enzyme (ACE), and angiotensin-II levels, were measured. The mean±standard deviation (SD) age and body mass index were 57.1±11.1years and 24.7±3.3kg/m , respectively. There were 54 subjects with NGM, 102 with prediabetes, and 251 with T2DM. The mean±SD angiotensin-II levels in these groups were 9.32±6.89, 12.89±10.39, and 17.00±15.28pg/mL, and the respective urinary albumin-to-creatinine ratios (ACRs) were 8.1±5.3, 13.3±17.3, and 30.7±51.9mg/g, which were significantly different among the groups. The serum angiotensin-II levels were correlated with levels of PRA, insulin resistance, C-reactive protein, and urinary ACR. Among RAS-related parameters, only the angiotensin-II level was significantly associated with urinary ACR after adjusting for relevant risk factors. Angiotensin-II may play an important role in the development of albuminuria, particularly in subjects with impaired glucose metabolism. |
Author | Park, Kyong Soo Kim, Kyoung Min Lee, Dong-Hwa Kong, Sung Hye Jang, Hak Chul Lim, Soo Min, Se Hee Lee, Jie-Eun Oh, Tae Jung |
Author_xml | – sequence: 1 givenname: Se Hee surname: Min fullname: Min, Se Hee organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea – sequence: 2 givenname: Sung Hye surname: Kong fullname: Kong, Sung Hye organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea – sequence: 3 givenname: Jie-Eun surname: Lee fullname: Lee, Jie-Eun organization: Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea – sequence: 4 givenname: Dong-Hwa surname: Lee fullname: Lee, Dong-Hwa organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea – sequence: 5 givenname: Tae Jung surname: Oh fullname: Oh, Tae Jung organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea – sequence: 6 givenname: Kyoung Min surname: Kim fullname: Kim, Kyoung Min organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea – sequence: 7 givenname: Kyong Soo surname: Park fullname: Park, Kyong Soo organization: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea – sequence: 8 givenname: Hak Chul surname: Jang fullname: Jang, Hak Chul organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea – sequence: 9 givenname: Soo surname: Lim fullname: Lim, Soo email: limsoo@snu.ac.kr organization: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28797632$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV1rFDEUhoNU7If-hRLwxovOmsxHMgMiLaXqQsEbBe9CkjlTM2aSMclU9jf4p5t1d2_2psKBhOR533M47zk6cd4BQpeUrCih7P24GnsjtZ_mVUkoX5FcpHyBzmjLq6Jm5MdJvpOGFS0v-Sk6j3EkhLCmoa_QadnyjrOqPEN_b2L02shkvMN-wNI9GJ_AReOK9RpbeAQb8R-TfmJp1TIZtwQjsXE4LmoEnfafzodJWvxgF-0j4AmSVN6aOF3hOUAeVUGCeJX9e5w2M-ASHx4zbK1JS3yNXg7SRnizPy_Q9093326_FPdfP69vb-4LXTc0FVRVpNZ9LYnsFAAwqRRhqu0a0HUlSTPwqiGqHrhu2hJ6RjXv-2EANbQ1V1V1gd7tfOfgfy8Qk5hM1HkI6cAvUdCubBvSNSXP6NsjdPRLcHm6TNV5vXXbskxd7qlFTdCLOZhJho04rDkDH3aADj7GAIPQJv3beQrSWEGJ2KYqRnFIVWxTFSQX2crZkfzQ4Vnh9U6YQ4RHA0FEbcDpHEjI2Ynem-ctPh5ZaGuc0dL-gs3_GDwB0gPYgg |
CitedBy_id | crossref_primary_10_1016_j_scr_2021_102168 crossref_primary_10_1097_HJH_0000000000002444 crossref_primary_10_1002_cche_10351 crossref_primary_10_4103_pm_pm_169_19 crossref_primary_10_1016_j_cca_2025_120154 crossref_primary_10_1016_j_jdiacomp_2020_107574 crossref_primary_10_1007_s00394_021_02595_z crossref_primary_10_1016_j_bone_2019_115041 crossref_primary_10_1080_21623945_2023_2249763 crossref_primary_10_1016_j_bcp_2023_115659 crossref_primary_10_3390_ijms231911203 |
Cites_doi | 10.1016/S0140-6736(11)60784-8 10.2147/VHRM.S1905 10.2337/diab.25.10.969 10.1210/jcem-66-2-454 10.1373/clinchem.2008.118000 10.1016/S0140-6736(02)08090-X 10.1038/ki.1977.132 10.1111/j.1365-2265.1982.tb01588.x 10.1007/BF00280883 10.1152/physrev.1977.57.2.313 10.2337/diacare.28.1.164 10.1042/cs0560255 10.2337/diab.24.9.833 10.1111/j.1365-2796.1994.tb01080.x 10.1042/CS20130344 10.1016/j.atherosclerosis.2010.05.020 10.1001/archinte.1977.03630190020008 10.4239/wjd.v3.i1.1 10.1210/jc.2016-1002 10.1152/ajpcell.00287.2006 10.1016/j.mce.2012.05.017 10.1016/j.jacc.2005.05.051 10.2337/diabetes.54.6.1615 10.1517/14728222.11.8.1011 10.1016/S0140-6736(02)08089-3 10.1681/ASN.2006050517 10.1016/S0140-6736(99)12323-7 10.1093/ajh/2.5.382 10.7326/0003-4819-130-6-199903160-00002 10.1001/jama.286.15.1882 10.1016/j.bbadis.2013.08.006 10.1016/j.ijcard.2005.03.053 10.3803/EnM.2013.28.1.26 10.1507/endocrj.48.25 10.2337/dc16-S005 10.1046/j.1523-1755.2000.07715.x |
ContentType | Journal Article |
Copyright | 2017 Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. Copyright Elsevier Limited Oct 1, 2017 |
Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Oct 1, 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BENPR CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH K6X K9- K9. KB0 M0R M0S M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1016/j.jdiacomp.2017.07.002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library British Nursing Index Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database ProQuest research library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-460X |
EndPage | 1505 |
ExternalDocumentID | 28797632 10_1016_j_jdiacomp_2017_07_002 S1056872717303471 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABGSF ABJNI ABMAC ABMZM ABUDA ABUWG ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKRA AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKNYI BKOJK BLXMC BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 D-I DU5 DWQXO EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HDZ HMCUK HMK HMO HVGLF HZ~ IHE J1W K-O K9- KOM L7B LZ1 M0R M1P M29 M2O M41 MO0 N9A NAPCQ O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ SV3 T5K UKHRP WOW WUQ Z5R ~G- 3V. AACTN AAIAV ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR RIG AAYXX AFCTW AGRNS ALIPV CITATION CGR CUY CVF ECM EIF NPM 7XB 8FK ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c451t-1b304cd4a0a9beee6abb06b895ec43a05f7350b4f7c582ed61c7ddffebf847b33 |
IEDL.DBID | .~1 |
ISSN | 1056-8727 1873-460X |
IngestDate | Mon Jul 21 11:40:12 EDT 2025 Fri Jul 25 02:43:57 EDT 2025 Wed Feb 19 02:41:19 EST 2025 Tue Jul 01 00:51:00 EDT 2025 Thu Apr 24 23:02:24 EDT 2025 Fri Feb 23 02:24:52 EST 2024 Tue Aug 26 16:31:51 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | albuminuria ACE type 2 diabetes RAS Angiotensin-II ALT Microvascular complications |
Language | English |
License | Copyright © 2017 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c451t-1b304cd4a0a9beee6abb06b895ec43a05f7350b4f7c582ed61c7ddffebf847b33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28797632 |
PQID | 1940564886 |
PQPubID | 1226340 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1928509527 proquest_journals_1940564886 pubmed_primary_28797632 crossref_citationtrail_10_1016_j_jdiacomp_2017_07_002 crossref_primary_10_1016_j_jdiacomp_2017_07_002 elsevier_sciencedirect_doi_10_1016_j_jdiacomp_2017_07_002 elsevier_clinicalkey_doi_10_1016_j_jdiacomp_2017_07_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2017 2017-10-00 2017-Oct 20171001 |
PublicationDateYYYYMMDD | 2017-10-01 |
PublicationDate_xml | – month: 10 year: 2017 text: October 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Philadelphia |
PublicationTitle | Journal of diabetes and its complications |
PublicationTitleAlternate | J Diabetes Complications |
PublicationYear | 2017 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Ribeiro-Oliveira, Nogueira, Pereira, Boas, Dos Santos, Simoes e Silva (bb0025) 2008; 4 Christlieb, Kaldany, D'Elia (bb0165) 1976; 25 Bae, Seo, Hur, Kim, Lee, Lee (bb0085) 2013; 28 Abuissa, Jones, Marso, O'Keefe (bb0050) 2005; 46 Mojahedi, Bonakdaran, Hami, Sheikhian, Shakeri, Aiatollahi (bb0135) 2009; 3 Patel, Parajuli, Oudit (bb0045) 2014; 126 Perez, Lespier, Jacobi, Oster, Katz, Vaamonde (bb0020) 1977; 137 Sasson, Cherney (bb0185) 2012; 3 Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0080) 1985; 28 Sena, Pereira, Seica (bb0140) 2013; 1832 Lindholm, Ibsen, Dahlof, Devereux, Beevers, de Faire (bb0150) 2002; 359 Nicola, Sidhom, El Khyat, Ibrahim, Salah, El Sayed (bb0110) 2001; 48 Luetscher, Kraemer, Wilson (bb0035) 1989; 2 Yusuf, Gerstein, Hoogwerf, Pogue, Bosch, Wolffenbuttel (bb0060) 2001; 286 Campbell, Nussberger, Stowasser, Danser, Morganti, Frandsen (bb0070) 2009; 55 Muniyappa, Yavuz (bb0100) 2013; 378 Ferriss, Sullivan, Gonggrijp, Cole, O'Sullivan (bb0105) 1982; 17 Mehta, Griendling (bb0095) 2007; 292 Leehey, Singh, Alavi, Singh (bb0115) 2000; 77 Gossain, Werk, Sholiton, Srivastava, Knowles (bb0160) 1975; 24 American Diabetes Association (bb0065) 2016; 39 Mogensen (bb0180) 1994; 235 de Zeeuw, Parving, Henning (bb0190) 2006; 17 HOPE-Study (bb0055) 2000; 355 de Chatel, Weidmann, Flammer, Ziegler, Beretta-Piccoli, Vetter (bb0155) 1977; 12 Erdmann (bb0195) 2006; 107 Bryer-Ash, Fraze, Luetscher (bb0030) 1988; 66 Ling, Vamvakas, Schaefer, Schnittler, Schaefer, Heidland (bb0120) 1995; 10 Han, Liu, Liu, Li (bb0130) 2010; 212 Dahlof, Devereux, Kjeldsen, Julius, Beevers, de Faire (bb0145) 2002; 359 Joseph, Echouffo-Tcheugui, Kalyani, Yeh, Bertoni, Effoe (bb0170) 2016; 101 Peach (bb0040) 1977; 57 Levey, Bosch, Lewis, Greene, Rogers, Roth (bb0075) 1999; 130 (bb0005) 2015 Tojo, Asaba, Onozato (bb0125) 2007; 11 Gross, de Azevedo, Silveiro, Canani, Caramori, Zelmanovitz (bb0175) 2005; 28 Blaha, Budoff, DeFilippis, Blankstein, Rivera, Agatston (bb0090) 2011; 378 Brownlee (bb0010) 2005; 54 Burden, Thurston (bb0015) 1979; 56 Matthews (10.1016/j.jdiacomp.2017.07.002_bb0080) 1985; 28 Sasson (10.1016/j.jdiacomp.2017.07.002_bb0185) 2012; 3 Lindholm (10.1016/j.jdiacomp.2017.07.002_bb0150) 2002; 359 (10.1016/j.jdiacomp.2017.07.002_bb0005) 2015 Bryer-Ash (10.1016/j.jdiacomp.2017.07.002_bb0030) 1988; 66 Joseph (10.1016/j.jdiacomp.2017.07.002_bb0170) 2016; 101 de Chatel (10.1016/j.jdiacomp.2017.07.002_bb0155) 1977; 12 de Zeeuw (10.1016/j.jdiacomp.2017.07.002_bb0190) 2006; 17 Ribeiro-Oliveira (10.1016/j.jdiacomp.2017.07.002_bb0025) 2008; 4 Campbell (10.1016/j.jdiacomp.2017.07.002_bb0070) 2009; 55 Dahlof (10.1016/j.jdiacomp.2017.07.002_bb0145) 2002; 359 Burden (10.1016/j.jdiacomp.2017.07.002_bb0015) 1979; 56 Ferriss (10.1016/j.jdiacomp.2017.07.002_bb0105) 1982; 17 Sena (10.1016/j.jdiacomp.2017.07.002_bb0140) 2013; 1832 Gross (10.1016/j.jdiacomp.2017.07.002_bb0175) 2005; 28 HOPE-Study (10.1016/j.jdiacomp.2017.07.002_bb0055) 2000; 355 Mehta (10.1016/j.jdiacomp.2017.07.002_bb0095) 2007; 292 Yusuf (10.1016/j.jdiacomp.2017.07.002_bb0060) 2001; 286 Nicola (10.1016/j.jdiacomp.2017.07.002_bb0110) 2001; 48 Christlieb (10.1016/j.jdiacomp.2017.07.002_bb0165) 1976; 25 Han (10.1016/j.jdiacomp.2017.07.002_bb0130) 2010; 212 Muniyappa (10.1016/j.jdiacomp.2017.07.002_bb0100) 2013; 378 Brownlee (10.1016/j.jdiacomp.2017.07.002_bb0010) 2005; 54 Tojo (10.1016/j.jdiacomp.2017.07.002_bb0125) 2007; 11 Levey (10.1016/j.jdiacomp.2017.07.002_bb0075) 1999; 130 Gossain (10.1016/j.jdiacomp.2017.07.002_bb0160) 1975; 24 Perez (10.1016/j.jdiacomp.2017.07.002_bb0020) 1977; 137 Erdmann (10.1016/j.jdiacomp.2017.07.002_bb0195) 2006; 107 Mojahedi (10.1016/j.jdiacomp.2017.07.002_bb0135) 2009; 3 Patel (10.1016/j.jdiacomp.2017.07.002_bb0045) 2014; 126 Luetscher (10.1016/j.jdiacomp.2017.07.002_bb0035) 1989; 2 Bae (10.1016/j.jdiacomp.2017.07.002_bb0085) 2013; 28 Mogensen (10.1016/j.jdiacomp.2017.07.002_bb0180) 1994; 235 Peach (10.1016/j.jdiacomp.2017.07.002_bb0040) 1977; 57 Abuissa (10.1016/j.jdiacomp.2017.07.002_bb0050) 2005; 46 American Diabetes Association (10.1016/j.jdiacomp.2017.07.002_bb0065) 2016; 39 Leehey (10.1016/j.jdiacomp.2017.07.002_bb0115) 2000; 77 Blaha (10.1016/j.jdiacomp.2017.07.002_bb0090) 2011; 378 Ling (10.1016/j.jdiacomp.2017.07.002_bb0120) 1995; 10 |
References_xml | – volume: 101 start-page: 1770 year: 2016 end-page: 1778 ident: bb0170 article-title: Aldosterone, renin, and diabetes mellitus in African Americans: the Jackson heart study publication-title: J Clin Endocrinol Metab – volume: 17 start-page: 261 year: 1982 end-page: 269 ident: bb0105 article-title: Plasma angiotensin II and aldosterone in unselected diabetic patients publication-title: Clin Endocrinol – volume: 4 start-page: 787 year: 2008 end-page: 803 ident: bb0025 article-title: The renin-angiotensin system and diabetes: an update publication-title: Vasc Health Risk Manag – volume: 48 start-page: 25 year: 2001 end-page: 31 ident: bb0110 article-title: Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy publication-title: Endocr J – volume: 28 start-page: 412 year: 1985 end-page: 419 ident: bb0080 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – volume: 66 start-page: 454 year: 1988 end-page: 458 ident: bb0030 article-title: Plasma renin and prorenin (inactive renin) in diabetes mellitus: effects of intravenous furosemide publication-title: J Clin Endocrinol Metab – volume: 212 start-page: 206 year: 2010 end-page: 212 ident: bb0130 article-title: Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells publication-title: Atherosclerosis – volume: 107 start-page: 147 year: 2006 end-page: 153 ident: bb0195 article-title: Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes publication-title: Int J Cardiol – volume: 137 start-page: 852 year: 1977 end-page: 855 ident: bb0020 article-title: Hyporeninemia and hypoaldosteronism in diabetes mellitus publication-title: Arch Intern Med – volume: 77 start-page: S93 year: 2000 end-page: S98 ident: bb0115 article-title: Role of angiotensin II in diabetic nephropathy publication-title: Kidney Int Suppl – volume: 359 start-page: 995 year: 2002 end-page: 1003 ident: bb0145 article-title: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol publication-title: Lancet – volume: 46 start-page: 821 year: 2005 end-page: 826 ident: bb0050 article-title: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials publication-title: J Am Coll Cardiol – volume: 39 start-page: S13 year: 2016 end-page: S22 ident: bb0065 article-title: 2. Classification and diagnosis of diabetes publication-title: Diabetes Care – volume: 10 start-page: 1305 year: 1995 end-page: 1312 ident: bb0120 article-title: Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells publication-title: Nephrol Dial Transplant – volume: 126 start-page: 471 year: 2014 end-page: 482 ident: bb0045 article-title: Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications publication-title: Clin Sci (Lond) – volume: 292 start-page: C82 year: 2007 end-page: C97 ident: bb0095 article-title: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system publication-title: Am J Phys Cell Phys – volume: 3 start-page: 1 year: 2012 end-page: 6 ident: bb0185 article-title: Renal hyperfiltration related to diabetes mellitus and obesity in human disease publication-title: World J Diabetes – volume: 54 start-page: 1615 year: 2005 end-page: 1625 ident: bb0010 article-title: The pathobiology of diabetic complications: a unifying mechanism publication-title: Diabetes – volume: 28 start-page: 26 year: 2013 end-page: 32 ident: bb0085 article-title: Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects publication-title: Endocrinol Metab (Seoul) – volume: 55 start-page: 867 year: 2009 end-page: 877 ident: bb0070 article-title: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement publication-title: Clin Chem – volume: 2 start-page: 382 year: 1989 end-page: 386 ident: bb0035 article-title: Prorenin and vascular complications of diabetes publication-title: Am J Hypertens – volume: 57 start-page: 313 year: 1977 end-page: 370 ident: bb0040 article-title: Renin-angiotensin system: biochemistry and mechanisms of action publication-title: Physiol Rev – volume: 3 start-page: 12 year: 2009 end-page: 16 ident: bb0135 article-title: Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus publication-title: Iran J Kidney Dis – year: 2015 ident: bb0005 publication-title: IDF Diabetes – volume: 24 start-page: 833 year: 1975 end-page: 835 ident: bb0160 article-title: Plasma renin activity in juvenile diabetes mellitus and effect of diazoxide publication-title: Diabetes – volume: 130 start-page: 461 year: 1999 end-page: 470 ident: bb0075 article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group publication-title: Ann Intern Med – volume: 25 start-page: 969 year: 1976 end-page: 974 ident: bb0165 article-title: Plasma renin activity and hypertension in diabetes mellitus publication-title: Diabetes – volume: 286 start-page: 1882 year: 2001 end-page: 1885 ident: bb0060 article-title: Ramipril and the development of diabetes publication-title: JAMA – volume: 28 start-page: 164 year: 2005 end-page: 176 ident: bb0175 article-title: Diabetic nephropathy: diagnosis, prevention, and treatment publication-title: Diabetes Care – volume: 56 start-page: 255 year: 1979 end-page: 259 ident: bb0015 article-title: Plasma renin activity in diabetes mellitus publication-title: Clin Sci (Lond) – volume: 355 start-page: 253 year: 2000 end-page: 259 ident: bb0055 article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators publication-title: Lancet – volume: 378 start-page: 684 year: 2011 end-page: 692 ident: bb0090 article-title: Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study publication-title: Lancet – volume: 1832 start-page: 2216 year: 2013 end-page: 2231 ident: bb0140 article-title: Endothelial dysfunction - a major mediator of diabetic vascular disease publication-title: Biochim Biophys Acta – volume: 378 start-page: 59 year: 2013 end-page: 69 ident: bb0100 article-title: Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act publication-title: Mol Cell Endocrinol – volume: 11 start-page: 1011 year: 2007 end-page: 1018 ident: bb0125 article-title: Suppressing renal NADPH oxidase to treat diabetic nephropathy publication-title: Expert Opin Ther Targets – volume: 235 start-page: 297 year: 1994 end-page: 316 ident: bb0180 article-title: Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension publication-title: J Intern Med – volume: 359 start-page: 1004 year: 2002 end-page: 1010 ident: bb0150 article-title: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol publication-title: Lancet – volume: 12 start-page: 412 year: 1977 end-page: 421 ident: bb0155 article-title: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus publication-title: Kidney Int – volume: 17 start-page: 2100 year: 2006 end-page: 2105 ident: bb0190 article-title: Microalbuminuria as an early marker for cardiovascular disease publication-title: J Am Soc Nephrol – volume: 378 start-page: 684 year: 2011 ident: 10.1016/j.jdiacomp.2017.07.002_bb0090 article-title: Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study publication-title: Lancet doi: 10.1016/S0140-6736(11)60784-8 – volume: 4 start-page: 787 year: 2008 ident: 10.1016/j.jdiacomp.2017.07.002_bb0025 article-title: The renin-angiotensin system and diabetes: an update publication-title: Vasc Health Risk Manag doi: 10.2147/VHRM.S1905 – volume: 25 start-page: 969 year: 1976 ident: 10.1016/j.jdiacomp.2017.07.002_bb0165 article-title: Plasma renin activity and hypertension in diabetes mellitus publication-title: Diabetes doi: 10.2337/diab.25.10.969 – volume: 66 start-page: 454 year: 1988 ident: 10.1016/j.jdiacomp.2017.07.002_bb0030 article-title: Plasma renin and prorenin (inactive renin) in diabetes mellitus: effects of intravenous furosemide publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-66-2-454 – volume: 55 start-page: 867 year: 2009 ident: 10.1016/j.jdiacomp.2017.07.002_bb0070 article-title: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement publication-title: Clin Chem doi: 10.1373/clinchem.2008.118000 – volume: 359 start-page: 1004 year: 2002 ident: 10.1016/j.jdiacomp.2017.07.002_bb0150 article-title: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol publication-title: Lancet doi: 10.1016/S0140-6736(02)08090-X – volume: 12 start-page: 412 year: 1977 ident: 10.1016/j.jdiacomp.2017.07.002_bb0155 article-title: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus publication-title: Kidney Int doi: 10.1038/ki.1977.132 – year: 2015 ident: 10.1016/j.jdiacomp.2017.07.002_bb0005 – volume: 17 start-page: 261 year: 1982 ident: 10.1016/j.jdiacomp.2017.07.002_bb0105 article-title: Plasma angiotensin II and aldosterone in unselected diabetic patients publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.1982.tb01588.x – volume: 28 start-page: 412 year: 1985 ident: 10.1016/j.jdiacomp.2017.07.002_bb0080 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 10 start-page: 1305 year: 1995 ident: 10.1016/j.jdiacomp.2017.07.002_bb0120 article-title: Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells publication-title: Nephrol Dial Transplant – volume: 57 start-page: 313 year: 1977 ident: 10.1016/j.jdiacomp.2017.07.002_bb0040 article-title: Renin-angiotensin system: biochemistry and mechanisms of action publication-title: Physiol Rev doi: 10.1152/physrev.1977.57.2.313 – volume: 28 start-page: 164 year: 2005 ident: 10.1016/j.jdiacomp.2017.07.002_bb0175 article-title: Diabetic nephropathy: diagnosis, prevention, and treatment publication-title: Diabetes Care doi: 10.2337/diacare.28.1.164 – volume: 56 start-page: 255 year: 1979 ident: 10.1016/j.jdiacomp.2017.07.002_bb0015 article-title: Plasma renin activity in diabetes mellitus publication-title: Clin Sci (Lond) doi: 10.1042/cs0560255 – volume: 24 start-page: 833 year: 1975 ident: 10.1016/j.jdiacomp.2017.07.002_bb0160 article-title: Plasma renin activity in juvenile diabetes mellitus and effect of diazoxide publication-title: Diabetes doi: 10.2337/diab.24.9.833 – volume: 235 start-page: 297 year: 1994 ident: 10.1016/j.jdiacomp.2017.07.002_bb0180 article-title: Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension publication-title: J Intern Med doi: 10.1111/j.1365-2796.1994.tb01080.x – volume: 126 start-page: 471 year: 2014 ident: 10.1016/j.jdiacomp.2017.07.002_bb0045 article-title: Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications publication-title: Clin Sci (Lond) doi: 10.1042/CS20130344 – volume: 212 start-page: 206 year: 2010 ident: 10.1016/j.jdiacomp.2017.07.002_bb0130 article-title: Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2010.05.020 – volume: 137 start-page: 852 year: 1977 ident: 10.1016/j.jdiacomp.2017.07.002_bb0020 article-title: Hyporeninemia and hypoaldosteronism in diabetes mellitus publication-title: Arch Intern Med doi: 10.1001/archinte.1977.03630190020008 – volume: 3 start-page: 1 year: 2012 ident: 10.1016/j.jdiacomp.2017.07.002_bb0185 article-title: Renal hyperfiltration related to diabetes mellitus and obesity in human disease publication-title: World J Diabetes doi: 10.4239/wjd.v3.i1.1 – volume: 101 start-page: 1770 year: 2016 ident: 10.1016/j.jdiacomp.2017.07.002_bb0170 article-title: Aldosterone, renin, and diabetes mellitus in African Americans: the Jackson heart study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-1002 – volume: 292 start-page: C82 year: 2007 ident: 10.1016/j.jdiacomp.2017.07.002_bb0095 article-title: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system publication-title: Am J Phys Cell Phys doi: 10.1152/ajpcell.00287.2006 – volume: 378 start-page: 59 year: 2013 ident: 10.1016/j.jdiacomp.2017.07.002_bb0100 article-title: Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2012.05.017 – volume: 46 start-page: 821 year: 2005 ident: 10.1016/j.jdiacomp.2017.07.002_bb0050 article-title: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.05.051 – volume: 54 start-page: 1615 year: 2005 ident: 10.1016/j.jdiacomp.2017.07.002_bb0010 article-title: The pathobiology of diabetic complications: a unifying mechanism publication-title: Diabetes doi: 10.2337/diabetes.54.6.1615 – volume: 11 start-page: 1011 year: 2007 ident: 10.1016/j.jdiacomp.2017.07.002_bb0125 article-title: Suppressing renal NADPH oxidase to treat diabetic nephropathy publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.11.8.1011 – volume: 359 start-page: 995 year: 2002 ident: 10.1016/j.jdiacomp.2017.07.002_bb0145 article-title: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol publication-title: Lancet doi: 10.1016/S0140-6736(02)08089-3 – volume: 17 start-page: 2100 year: 2006 ident: 10.1016/j.jdiacomp.2017.07.002_bb0190 article-title: Microalbuminuria as an early marker for cardiovascular disease publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006050517 – volume: 355 start-page: 253 year: 2000 ident: 10.1016/j.jdiacomp.2017.07.002_bb0055 article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators publication-title: Lancet doi: 10.1016/S0140-6736(99)12323-7 – volume: 2 start-page: 382 year: 1989 ident: 10.1016/j.jdiacomp.2017.07.002_bb0035 article-title: Prorenin and vascular complications of diabetes publication-title: Am J Hypertens doi: 10.1093/ajh/2.5.382 – volume: 130 start-page: 461 year: 1999 ident: 10.1016/j.jdiacomp.2017.07.002_bb0075 article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group publication-title: Ann Intern Med doi: 10.7326/0003-4819-130-6-199903160-00002 – volume: 3 start-page: 12 year: 2009 ident: 10.1016/j.jdiacomp.2017.07.002_bb0135 article-title: Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus publication-title: Iran J Kidney Dis – volume: 286 start-page: 1882 year: 2001 ident: 10.1016/j.jdiacomp.2017.07.002_bb0060 article-title: Ramipril and the development of diabetes publication-title: JAMA doi: 10.1001/jama.286.15.1882 – volume: 1832 start-page: 2216 year: 2013 ident: 10.1016/j.jdiacomp.2017.07.002_bb0140 article-title: Endothelial dysfunction - a major mediator of diabetic vascular disease publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2013.08.006 – volume: 107 start-page: 147 year: 2006 ident: 10.1016/j.jdiacomp.2017.07.002_bb0195 article-title: Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2005.03.053 – volume: 28 start-page: 26 year: 2013 ident: 10.1016/j.jdiacomp.2017.07.002_bb0085 article-title: Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects publication-title: Endocrinol Metab (Seoul) doi: 10.3803/EnM.2013.28.1.26 – volume: 48 start-page: 25 year: 2001 ident: 10.1016/j.jdiacomp.2017.07.002_bb0110 article-title: Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy publication-title: Endocr J doi: 10.1507/endocrj.48.25 – volume: 39 start-page: S13 year: 2016 ident: 10.1016/j.jdiacomp.2017.07.002_bb0065 article-title: 2. Classification and diagnosis of diabetes publication-title: Diabetes Care doi: 10.2337/dc16-S005 – volume: 77 start-page: S93 year: 2000 ident: 10.1016/j.jdiacomp.2017.07.002_bb0115 article-title: Role of angiotensin II in diabetic nephropathy publication-title: Kidney Int Suppl doi: 10.1046/j.1523-1755.2000.07715.x |
SSID | ssj0006551 |
Score | 2.235031 |
Snippet | The relationship between the renin–angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components... The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS components... Objectives The relationship between the renin-angiotensin system (RAS) and diabetes has been studied for many years. However, studies that assessed RAS... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1499 |
SubjectTerms | Aged albuminuria Albuminuria - blood Albuminuria - complications Albuminuria - immunology Albuminuria - metabolism Angiotensin II - blood Angiotensin-II Biomarkers Blood pressure Cross-Sectional Studies Diabetes Diabetes Mellitus, Type 2 - complications Diabetic Angiopathies - complications Diabetic Angiopathies - diagnosis Diabetic Angiopathies - epidemiology Diabetic Angiopathies - physiopathology Diabetic Nephropathies - blood Diabetic Nephropathies - complications Diabetic Nephropathies - immunology Diabetic Nephropathies - metabolism Early Diagnosis Endothelium, Vascular - immunology Endothelium, Vascular - physiopathology Female Glucose Hospitals, University Humans Insulin Resistance Kinases Male Metabolism Microvascular complications Microvessels - immunology Microvessels - physiopathology Middle Aged Mortality Outpatient Clinics, Hospital Peptides Prediabetic State - complications RAS Republic of Korea - epidemiology Risk Factors type 2 diabetes Up-Regulation Vasculitis - complications Vasculitis - diagnosis Vasculitis - epidemiology Vasculitis - physiopathology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagSIgL4t2FgozEsaGJH7FzQghRtUjlRKW9WXbioF2lztJsfgV_mpnEDj0A5Zp4rMQznvk8_uwh5J2urHMAOzJwfHUmKsszp12TMZe3lVVNU0ypi4uv5dml-LKW65hwGyKtMvnEyVE3fY058hNYbEOsBnMrP-x-ZFg1CndXYwmNu-QeXl2GlC61XhZcEF2n8otYXB5mPVM3Tghv329h_JG2jfQuNV3gGVMrfwhOfwOfUxA6fUQeRvRIP87qfkzu-PCE3L-I--NPyc8bo037ltrwfdNPHPWQnZ_TDhlCA8XcK514yZswggHSTaDD6DAjE18GRLIdjXx2euX3YCvdZrg6prtrn_K1x9B_QzGJSxlND6FxB9B-HJ6Ry9PP3z6dZbHcQlYLWeyzwvFc1I2wua2c974ELeal05X0teA2l63iMneiVbXUzDdlUYMu29a7FkKc4_w5OQh98IeEWuGF1bypJIP2EpTPLROal1XhtNJuRWQaZ1PHu8ixJEZnEulsa5J-DOrH5LhNzlbkZJHbzbdx3CqhkhpNOmsK3tFAwLhVslokIxqZUcZ_yR4lizHRJwzmtwWvyNvlNcxm3KKxwfcjtmEaIJxkakVezJa2_CisbQE7cvby352_Ig_wS2bC4RE52F-P_jUAp717M82OX0FoGmg priority: 102 providerName: ProQuest |
Title | Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1056872717303471 https://dx.doi.org/10.1016/j.jdiacomp.2017.07.002 https://www.ncbi.nlm.nih.gov/pubmed/28797632 https://www.proquest.com/docview/1940564886 https://www.proquest.com/docview/1928509527 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Na9wwEBUhhdJL6Xe3TYMKPUZZ25Is-ZiGhN2WLKVtYG9GsuXixfEu8fraP5A_nRlZ3qbQkkIvNrZnjK0ZzzyPniRCPujMWAuwg0HgK5jIDGdW25IlNqoyo8oy9qWLi0U6uxSflnK5R07HsTBIqwyxf4jpPlqHM9PQmtNNXU-_4ZrxGtJvDE7KhR9HLoRCLz_--YvmkUq_BCMKM5S-M0p4dbwCGyB1Gyleyk_iGcorf0hQfwOgPhGdPyGPA4KkJ8NDPiV7rn1GHl6EPvLn5OZOi9N1RU37o157nnrL5nPaIEuoo1h_pZ6bXLc9OCGtW9r1Fqsy4WKLaLahgdNOr9wW_KWpu6sjurl2Y832CO5fUizk0oSOJ0G4AXjfdy_I5fnZ99MZC0susELIeMtiyyNRlMJEJrPOuRQsGaVWZ9IVgptIVorLyIpKFVInrkzjAuxZVc5WkOYs5y_Jfrtu3WtCjXDCaF5mMgF5CQ7ATSI0T7PYaqXthMixnfMizEeOy2I0-Ug8W-WjfXK0Tx5hV3kyIdOd3maYkeNeDTWaMR_Hm0KEzCFp3KuZ7TR_88p_0j0YPSYPcaHL4wwAcgpBM52Q97vL8EVjN41p3bpHmUQDjJOJmpBXg6ftXhT-bwE_8uTNfzzYW_IIjwZG4gHZ31737h0gq6099J8ObNVSHZIHJ_PPswXsP54tvny9Bc6BKOM |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWwm4oPLs0gJGgltDE8fO44AQj1a7tLtCqJV6M3bioF2lydJshPgN_Bd-I-PEDj0A5dJr7ImczPjzN-OxB-B5kkqlkHZ4CHyZx1IZeipRuUeVX6QyzvOgC13M5tHklH0442cb8NOdhTFplQ4TO6DO68zEyPfR2ca1Gs0ter366pmqUWZ31ZXQ6M3iSH__hi5b82r6HvX7gtLDg5N3E89WFfAyxoO1Fyj04LOcSV-mSmsd4WD9SCUp1xkLpc-LOOS-YkWc8YTqPAoyHHJRaFUgkisTAEXI32QhujIj2Hx7MP_4acD-iHcFH005e8QZGl86k7x8uUSNm0Rxk1AWd1eG2mDOH5bDv9Hdbtk73ILblq-SN72B3YENXd2FGzO7I38PflzSL6kLIqsvi7rLiq-86ZSUJiepISbaS7pM6EXVosmTRUWaVpkYkG2sDHcuic2gJ-d6jdZZLprzPbK60C5CvIfvz4kJGxNK3EPsXKIz0Tb34fRaVPEARlVd6W0gkmkmkzBPOcX-HM0tlJQlYZQGKokTNQbu_rPI7O3npghHKVya21I4_QijH-GbjXk6hv1BbtXf_3GlROzUKNzpVsRjgUvUlZLpIGn5T89r_kt211mMsCjUiN9zZgzPhmbED7MpJCtdt6YPTZA0chqP4WFvacOHojeNbDWkj_798qdwc3IyOxbH0_nRDtwyo-rTHXdhtL5o9WOkbWv1xM4VAp-ve3r-AqW5Wvc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcEOW5tICR4FaziWPncUAIUVZdSisOVNqbsRMH7SpNlmYjxG_gH_HrmEns0ANQLr3GnsjJvMefPYQ8TzNtDIQdDAxfzkSmI2ZSUzBugjLTSVGEfeni5DQ-OhPvF3KxRX76szAIq_Q2sTfURZNjjXwKyTb4ahC3eFo6WMTHw9nr9VeGHaRwp9W30xhE5Nh-_wbpW_tqfgi8fsH57N2nt0fMdRhguZDhhoUGsvm8EDrQmbHWxrDwIDZpJm0uIh3IMolkYESZ5DLltojDHJZfltaUYNUNFkPB_N-ASSHqWLIYkz3w7H3rR2xsDxaHJ5dOJ69eroD3CBlHaFnSXx7qyjp_cIx_C3x7Bzi7TW65yJW-GURtl2zZ-g7ZOXF783fJj0ucpk1Jdf1l2fT4-JrN57RCdFJLse5Le0z0su5A-Omypm1nsBrkBmuMoivqsPT03G5ATqtle35A1xfW14oP4P0FxQIy5dQ_hMkVpBVde4-cXQsj7pPtuqntQ0K1sEKnUZFJDvMlCF6kuUijOAtNmqRmQqT_zyp396BjO45KecDbSnn-KOSPCnCLnk_IdKRbDzeBXEmReDYqf84VLLMCZ3UlZTZSukhoiHD-i3bfS4xy9qhVv7VnQp6Nw2BJcHtI17bpcA5PIXyUPJmQB4OkjR8KeTXErRF_9O-XPyU7oJTqw_z0eI_cxEUNuMd9sr256OxjiN825kmvKJR8vm7N_AWr_F3H |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+angiotensin-II+levels+with+albuminuria+in+subjects+with+normal+glucose+metabolism%2C+prediabetes%2C+and+type+2+diabetes+mellitus&rft.jtitle=Journal+of+diabetes+and+its+complications&rft.au=Min%2C+Se+Hee&rft.au=Kong%2C+Sung+Hye&rft.au=Lee%2C+Jie-Eun&rft.au=Lee%2C+Dong-Hwa&rft.date=2017-10-01&rft.issn=1873-460X&rft.eissn=1873-460X&rft.volume=31&rft.issue=10&rft.spage=1499&rft_id=info:doi/10.1016%2Fj.jdiacomp.2017.07.002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1056-8727&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1056-8727&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1056-8727&client=summon |